Markets:

Overview

News

Currencies

International

Treasuries

Kyverna Therapeutics, Inc. - Common Stock (NQ:KYTX)

6.620 -0.180 (-2.65%)

Delayed Quote Updated: 11:08 AM EDT, Oct 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Kyverna Therapeutics, Inc. - Common Stock

< Previous 1 2 Next >

Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026? ↗

June 08, 2026

A clinical-stage innovator faces off against an established biotech powerhouse, each with distinct financials and risk profiles shaping their 2026 outlook.

Via The Motley Fool

Which stocks are moving before the opening bell on Wednesday? ↗

April 22, 2026

Via Chartmill

Why Kyverna Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket ↗

April 22, 2026

Kyverna Therapeutics Inc (NASDAQ: KYTX) shares rose 25.8% in pre-market trading after positive trial results for miv-cel. Other gainers include HCAI, ELPW, and ALP.

Via Benzinga

On Thursday, there are stocks with unusual volume. Let's take a look. ↗

December 18, 2025

Let's have a look at the stocks with an unusual volume in today's session.

Via Chartmill

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

December 17, 2025

Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

December 17, 2025

Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

These stocks are gapping in today's session ↗

December 17, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.

Via Chartmill

What's going on in today's pre-market session ↗

December 17, 2025

The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

Stock Market Today, Dec. 15: U.S Stocks Ease as Investors Wait for Rate Clarity ↗

December 15, 2025

Today, Dec. 15, 2025, stocks dipped as growth shares faltered and traders assessed trade risk alongside Fed commentary.

Via The Motley Fool

Which stocks are moving on Monday? ↗

December 15, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Monday's session: top gainers and losers ↗

December 15, 2025

Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Which stocks are gapping on Monday? ↗

December 15, 2025

In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

KYTX Stock Just Surged 11% Today – What Is The Connection With Stiff Person Syndrome? ↗

December 15, 2025

In the KYSA-8 trial, a single infusion of miv-cel delivered sustained improvements across both primary and secondary measures of Stiff Person Syndrome.

Via Stocktwits

Palo Alto, Vizsla Silver, NetEase And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

November 20, 2025

Via Benzinga

FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy ↗

November 04, 2025

William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty in its accelerated approval timeline.

Via Benzinga

Top movers in Wednesday's session ↗

October 08, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Kyverna Sets Pace In Race For Autoimmune CAR-T Approval By 2026 ↗

August 20, 2025

William Blair starts Kyverna coverage with Outperform, citing KYV-101's potential as the first FDA-approved CAR-T therapy in autoimmune disease.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 15, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 18, 2025

Via Benzinga

With Trials In Motion, Cash To 2027, Can Kyverna's Next Data Drop Turn The Stock Around? ↗

May 27, 2025

HC Wainwright upgrades Kyverna to Buy with a $5 target, citing upcoming trial data and a strong cash position that supports a runway into 2027.

Via Benzinga

This Commercial Metals Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

May 27, 2025

Via Benzinga

Top movers in Monday's after hours session ↗

March 17, 2025

As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 17, 2025

Via Benzinga

Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases ↗

September 25, 2024

Amgen tested its drug, Uplizna, in generalized myasthenia gravis, a market where Argenx's Vyvgart leads.

Via Investor's Business Daily

Toll Brothers Posts Strong Earnings, Joins Keysight, Coty, TJX And Other Big Stocks Moving Higher On Wednesday ↗

August 21, 2024

Via Benzinga

Home Depot, Paysafe And 3 Stocks To Watch Heading Into Tuesday ↗

August 13, 2024

Via Benzinga

KYTX Stock Earnings: Kyverna Therapeutics Misses EPS for Q2 2024 ↗

August 12, 2024

KYTX stock results show that Kyverna Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Cell Therapy Mostly Used For Blood Cancer Shows Efficacy In Autoimmune Diseases As Well, But There Are Challenges ↗

July 19, 2024

CAR-T therapy, originally used for blood cancers, shows promising results in treating lupus, as evidenced by Janina Paech's remarkable remission. This breakthrough offers new hope for autoimmune...

Via Benzinga

Bank Of America, Morgan Stanley And Other 3 Stocks To Watch Heading Into Tuesday ↗

July 16, 2024

Via Benzinga

Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 14, 2024

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.